The Relationship between Body Composition, Fatty Acid Metabolism and Diet in Spinal Muscular Atrophy

Spinal Muscular Atrophy: In the Challenge Lies a Solution

(2021) Brunhilde Wirth   TRENDS IN NEUROSCIENCES

Fatty acid metabolism in the progression and resolution of CNS disorders

(2020) Jeroen F.J. Bogie et al.   ADVANCED DRUG DELIVERY REVIEWS

Sterol regulatory element binding protein 1 couples mechanical cues and lipid metabolism

(2019) Rebecca Bertolio et al.   Nature Communications

CHP1 Regulates Compartmentalized Glycerolipid Synthesis by Activating GPAT4

(2019) Xiphias Ge Zhu et al.   MOLECULAR CELL

Lipid Biomarkers for Amyotrophic Lateral Sclerosis

(2019) Jose-Luis González De Aguilar   Frontiers in Neurology

The mechanisms of pharmacokinetic food-drug interactions – A perspective from the UNGAP group

(2019) Mirko Koziolek et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

Abnormal fatty acid metabolism is a core component of spinal muscular atrophy

(2019) Marc‐Olivier Deguise et al.   Annals of Clinical and Translational Neurology

Alterations in lipid metabolism of spinal cord linked to amyotrophic lateral sclerosis

(2019) Adriano Britto Chaves-Filho et al.   Scientific Reports

Low fat diets increase survival of a mouse model of spinal muscular atrophy

(2019) Marc‐Olivier Deguise et al.   Annals of Clinical and Translational Neurology

CHP1 reduction ameliorates spinal muscular atrophy pathology by restoring calcineurin activity and endocytosis

(2018) Eva Janzen et al.   BRAIN

Molecular Factors Involved in Spinal Muscular Atrophy Pathways as Possible Disease-modifying Candidates

(2018) Marianna A. Maretina et al.   CURRENT GENOMICS

OUP accepted manuscript

(2018)   HUMAN MOLECULAR GENETICS

Diagnosis and management of spinal muscular atrophy: Part 1: Recommendations for diagnosis, rehabilitation, orthopedic and nutritional care

(2018) Eugenio Mercuri et al.   NEUROMUSCULAR DISORDERS

Metabolic Reprogramming in Amyotrophic Lateral Sclerosis

(2018) M. Szelechowski et al.   Scientific Reports

Interventions Targeting Glucocorticoid-Krüppel-like Factor 15-Branched-Chain Amino Acid Signaling Improve Disease Phenotypes in Spinal Muscular Atrophy Mice

(2018) Lisa M. Walter et al.   EBioMedicine

Pathogenic commonalities between spinal muscular atrophy and amyotrophic lateral sclerosis: Converging roads to therapeutic development

(2017) Melissa Bowerman et al.   European Journal of Medical Genetics

Metabolic Dysfunctions in Amyotrophic Lateral Sclerosis Pathogenesis and Potential Metabolic Treatments

(2017) Tesfaye W. Tefera et al.   Frontiers in Neuroscience

The Biochemistry and Physiology of Mitochondrial Fatty Acid β-Oxidation and Its Genetic Disorders

(2016) Sander M. Houten et al.   Annual Review of Physiology

Describing nutrition in spinal muscular atrophy: A systematic review

(2016) Georgia E. Moore et al.   NEUROMUSCULAR DISORDERS

Nutritional Status and Nutrient Intake Challenges in Children With Spinal Muscular Atrophy

(2016) Nilesh M. Mehta et al.   PEDIATRIC NEUROLOGY

Regulation of Lipid Metabolism and Beyond

(2016) Youngah Jo et al.   International Journal of Endocrinology

Understanding the experiences and needs of individuals with Spinal Muscular Atrophy and their parents: a qualitative study

(2015) Ying Qian et al.   BMC Neurology

Responses to Fasting and Glucose Loading in a Cohort of Well Children with Spinal Muscular Atrophy Type II

(2015) Rebecca Hurst Davis et al.   JOURNAL OF PEDIATRICS

Spinal Muscular Atrophy

(2015) Stephen J. Kolb et al.   NEUROLOGIC CLINICS

KLF15 and PPARαCooperate to Regulate Cardiomyocyte Lipid Gene Expression and Oxidation

(2015) Domenick A. Prosdocimo et al.   PPAR Research

Predicted and Measured Resting Energy Expenditure in Children with Spinal Muscular Atrophy 2

(2014) Luisa Cutillo et al.   JOURNAL OF PEDIATRICS

Hypercaloric enteral nutrition in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled phase 2 trial

(2014) Anne-Marie Wills et al.   LANCET

Spinal muscular atrophy: Diagnosis and management in a new therapeutic era

(2014) W. David Arnold et al.   MUSCLE & NERVE

Elemental Diets May Reduce the Risk of Aspiration Pneumonia in Bedridden Gastrostomy-Fed Patients

(2013) Akira Horiuchi et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Spinal Muscular Atrophy: From Gene Discovery to Clinical Trials

(2013) Dian K. Nurputra et al.   ANNALS OF HUMAN GENETICS

Spinal muscular atrophy: a motor neuron disorder or a multi-organ disease?

(2013) Monir Shababi et al.   JOURNAL OF ANATOMY

Nutritional Practices at a Glance

(2013) Rebecca Hurst Davis et al.   JOURNAL OF CHILD NEUROLOGY

Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for ALS

(2013) Ettore Beghi et al.   Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

Early onset muscle weakness and disruption of muscle proteins in mouse models of spinal muscular atrophy

(2013) Justin G Boyer et al.   Skeletal Muscle

Glucose metabolism and pancreatic defects in spinal muscular atrophy

(2012) Melissa Bowerman et al.   ANNALS OF NEUROLOGY

Bioavailability of bioactive food compounds: a challenging journey to bioefficacy

(2012) Maarit J. Rein et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

SMN-inducing compounds for the treatment of spinal muscular atrophy

(2012) Monique A Lorson et al.   Future Medicinal Chemistry

Mouse models of SMA: tools for disease characterization and therapeutic development

(2012) Thomas W. Bebee et al.   HUMAN GENETICS

Observational study of caloric and nutrient intake, bone density, and body composition in infants and children with spinal muscular atrophy type I

(2012) Katherine E. Poruk et al.   NEUROMUSCULAR DISORDERS

Pan-ethnic carrier screening and prenatal diagnosis for spinal muscular atrophy: clinical laboratory analysis of >72 400 specimens

(2011) Elaine A Sugarman et al.   EUROPEAN JOURNAL OF HUMAN GENETICS

Spinal muscular atrophy

(2011) Adele D'Amico et al.   Orphanet Journal of Rare Diseases

Acyl-coenzyme A synthetases in metabolic control

(2010) Jessica M Ellis et al.   CURRENT OPINION IN LIPIDOLOGY

Role of carnitine in disease

(2010) Judith L Flanagan et al.   Nutrition & Metabolism

Therapeutic developments in spinal muscular atrophy

(2010) Douglas M. Sproule et al.   Therapeutic Advances in Neurological Disorders

Effect of diet on the survival and phenotype of a mouse model for spinal muscular atrophy

(2009) Matthew E.R. Butchbach et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Spinal muscular atrophy: why do low levels of survival motor neuron protein make motor neurons sick?

(2009) Arthur H. M. Burghes et al.   NATURE REVIEWS NEUROSCIENCE

Increased fat mass and high incidence of overweight despite low body mass index in patients with spinal muscular atrophy

(2009) Douglas M. Sproule et al.   NEUROMUSCULAR DISORDERS

Sustained improvement of spinal muscular atrophy mice treated with trichostatin a plus nutrition

(2008) Heather L. Narver et al.   ANNALS OF NEUROLOGY

Glucocorticoids and fatty acid metabolism in humans: fuelling fat redistribution in the metabolic syndrome

(2008) David P Macfarlane et al.   JOURNAL OF ENDOCRINOLOGY

Spinal muscular atrophy

(2008) Mitchell R Lunn et al.   LANCET

Plastin 3 Is a Protective Modifier of Autosomal Recessive Spinal Muscular Atrophy

(2008) G. E. Oprea et al.   SCIENCE

Mitochondrial Fatty-Acid Oxidation Disorders

(2008) Michelle Kompare et al.   Seminars in Pediatric Neurology